CA2115926A1 - Hepatitis c assay utilizing recombinant antigens to ns1 - Google Patents

Hepatitis c assay utilizing recombinant antigens to ns1

Info

Publication number
CA2115926A1
CA2115926A1 CA 2115926 CA2115926A CA2115926A1 CA 2115926 A1 CA2115926 A1 CA 2115926A1 CA 2115926 CA2115926 CA 2115926 CA 2115926 A CA2115926 A CA 2115926A CA 2115926 A1 CA2115926 A1 CA 2115926A1
Authority
CA
Canada
Prior art keywords
ala
val
leu
gly
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2115926
Other languages
English (en)
French (fr)
Inventor
Stephen H. Dailey
Suresh M. Desai
Sushil G. Devare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2115926A1 publication Critical patent/CA2115926A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA 2115926 1991-08-21 1992-08-21 Hepatitis c assay utilizing recombinant antigens to ns1 Abandoned CA2115926A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74856191A 1991-08-21 1991-08-21
US748,561 1991-08-21

Publications (1)

Publication Number Publication Date
CA2115926A1 true CA2115926A1 (en) 1993-03-04

Family

ID=25009968

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2115926 Abandoned CA2115926A1 (en) 1991-08-21 1992-08-21 Hepatitis c assay utilizing recombinant antigens to ns1

Country Status (6)

Country Link
EP (1) EP0600009A4 (zh)
JP (1) JPH06510191A (zh)
AU (1) AU2513592A (zh)
CA (1) CA2115926A1 (zh)
TW (1) TW213924B (zh)
WO (1) WO1993004088A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139100C (en) * 1993-04-27 2009-06-23 Geert Maertens New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
EP0992580B1 (en) * 1993-11-04 2005-03-09 Innogenetics N.V. Immunodominant human T-cell epitopes of Hepatitis C virus
US5610009A (en) * 1994-01-28 1997-03-11 Abbott Laboratories Mammalian expression systems for hepatitis C virus envelope genes
DE69526636D1 (de) * 1994-07-29 2002-06-13 Innogenetics Nv Gereinigte hepatitis-c-virus hüllproteine zur diagnostischen und therapeutischen verwendung
US6329157B1 (en) 1998-05-28 2001-12-11 Abbott Laboratories Antigen cocktails and uses thereof
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU216017B (hu) * 1987-11-18 1999-04-28 Chiron Corp. Eljárás HCV-1 polipeptidek, HCV-1 polinukleotidok, rekombináns vektorok és gazdasejtek, valamint immunesszé kit, hepatitis C vírusfertőzés elleni vakcinák, a fertőzés kimutatására szolgáló diagnosztikumok előállítására, és immunvizsgálati és vírustenyészt
US5124255A (en) * 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
HU225068B1 (en) * 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
WO1993004088A1 (en) 1993-03-04
TW213924B (zh) 1993-10-01
EP0600009A1 (en) 1994-06-08
EP0600009A4 (en) 1995-03-01
AU2513592A (en) 1993-03-16
JPH06510191A (ja) 1994-11-17

Similar Documents

Publication Publication Date Title
US5372928A (en) Hepatitis C virus isolates
Meyer et al. Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus
Li et al. Amino‐terminal epitopes are exposed when full‐length open reading frame 2 of hepatitis E virus is expressed in Escherichia coli, but carboxy‐terminal epitopes are masked
EP0472207B1 (en) Hepatitis C assay utilizing recombinant antigens
NL9002779A (nl) Viraal middel.
CA2003383A1 (en) Synthetic dna derived recombinant hiv antigens
US6593083B1 (en) Hepatitis C assay utilizing recombinant antigens
Khudyakov et al. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus
CA2115926A1 (en) Hepatitis c assay utilizing recombinant antigens to ns1
CA2070952A1 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
US5800982A (en) Antigenic peptides for growing hepatitis C virus, kit comprising the same and methods for its grouping using the same
EP1461357B1 (en) Novel hev antigenic peptide and methods
US5859230A (en) Non-A/non-B/non-C/non-D/non-E hepatitis agents and molecular cloning thereof
AU3063992A (en) Epitope mapping ot the c33c region of hcv
Jia et al. Host antibody response to viral structural and nonstructural proteins after hepatitis A virus infection
CA2116026C (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
US20090087832A1 (en) Nucleic acids and new polypeptides associated with and/or overlapping with hepatitis C virus core gene products
EP0600000A1 (en) Hepatitis c assay utilizing recombinant antigens from ns5 region
JP3669717B2 (ja) Ｃ型肝炎ウイルスのグルーピングのための抗原性ペプチド、それを含有するキットおよびそれを使用するグルーピング方法
WO1998029747A1 (en) Reagents and methods for detecting hepatitis gb virus antigen
JPH0656896A (ja) 血液伝播型非ａ非ｂ型肝炎ウイルス由来の抗原タンパク質を有する融合タンパク質
JPH06239894A (ja) 新規な非ａ非ｂ型肝炎ウイルス抗原ポリペプチド及び診断方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead